The Effect of the Care Bundle to be Applied to Obesity Surgery Patients on Surgical Site Infection and Patient Comfort
Bariatric Surgery Candidate
About this trial
This is an interventional prevention trial for Bariatric Surgery Candidate focused on measuring Surgical Site Infection, Bariatric Surgery, Care bundle, prevention package
Eligibility Criteria
Inclusion Criteria: 18 years and over undergoing sleeve gastrectomy surgery who volunteered to participate in the study Exclusion Criteria: under 18 years old Surgeries other than sleeve gastrectomy not willing to participate in the study
Sites / Locations
- Hatice ÇAKIRRecruiting
- Meryem YilmazRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Experimental
Experimental
Experimental
Experimental
Experimental
No Intervention
Surgical Site Infection (SSI) prevention package; Identification of risk factors
Surgical Site Infection (SSI) prevention package; Antibiotic prophylaxis
Surgical Site Infection (SSI) prevention package;achieving and maintaining normothermia
Surgical Site Infection (SSI) prevention package; maintenance of normoglycemia
Surgical Site Infection (SSI) prevention package;patient education
control group
Risk factors of the individual created in line with the literature; Advanced age, history of skin or soft tissue infection, DM, alcohol addiction, smoking, preoperative albumin <3.5 mg/dl, total bilirubin>1.0 mg/dl, immunosuppression, long postoperative stay, long preoperative stay, high BMI,ASA score > II,preoperative low Hgb level. Risk factors associated with the surgical procedure; Presence of drain, prolongation of surgery time, preoperative skin preparation, blood transfusion, non-sterile equipment, insufficient ventilation, heavy operating room traffic, insufficient hemostasis. Participants will be evaluated in terms of these risks.
determined antibiotic (active ingredient: imipenem cilastatin sodium)
Body temperature will be recorded with an infrared thermometer. The patient will be warmed with various passive heating techniques before and after the operation. To prevent hypothermia, the operating room ambient temperature will be kept in the range of 23-26°C.
In the 2017 guidelines, perioperative glycemic control with a blood glucose level of <200 mg/dL is recommended for patients with and without DM. Ideal blood glucose control should provide good glycemic control with a minimal incidence of hypoglycemia.
SSI definition, SSI signs and symptoms, Hand hygiene, smoking, hair removal in the operation area, shower and bath before surgery. Conditions that require hospitalization, factors affecting wound healing, wound care, control time and who should be contacted will be discussed.
Antibiotic prophylaxis is applied to both groups. In the clinic where the study will be conducted, the blood glucose level of patients with a diagnosis of DM is controlled (5 measurements per day). All patients are fasted after 21.00 in the evening. The blood glucose levels of patients without a diagnosis of DM are not routinely checked. The body temperature of the patients is not monitored intraoperatively. No extra intervention is applied to maintain normothermia in the clinic and operating room. There is no training on prevention of infection. There is no intervention in the control group.